Kevin Smyth

mFoundry, Inc. provides mobile financial services. Its mobile banking and mobile payments solutions are based upon a market-proven platform that was designed to help their clients create deeper, more valuable relationships with their customers. The company was founded by Rodney Aiglstorfer in 2004 and is headquartered in San Francisco, CA.

Melodeo, Inc. offers mobile podcasting solutions. The firm delivers music and other media via mobile phones and web. It also provides wireless customers with music, comedy, news, sports, and entertainment programs, including radio shows. The company was founded by Bill Valenti, Donald Davidge and Loreen Milbrath in 2003 and is headquartered in Seattle, WA.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.

Yeelion Online Network Technology (Beijing) Co. Ltd. is engaged in the provision of online digital media services. Its music software, Koowo, is a media player plug-in to auto search for matching lyrics, images and music videos. The company was founded in August 2005 and is headquartered in Beijing, China.

International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.

ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.

Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA.

Maritime Telecommunications Network, Inc. provides vital and satellite communication services. It offers connectivity, digital media, system integration, and equipment. The firm serves commercial shipping, cruise and ferry, energy, enterprise, government, mobile network operators, and yacht. The company was founded in 1981 and is headquartered in Miramar, FL.

Ignition Venture Partners (Ignition Venture) is a venture capital firm subsidiary of Ignition Partners Group founded in 2000 by Cameron Myhrvold, Jonathan D Roberts, Jon Anderson, and John Ludwig. The firm is headquartered in Bellevue, Washington.

Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada.

Liberty Dialysis LLC develops and operates dialysis clinics. It offers chronic kidney disease outreach and home dialysis programs for patients. The firm also partners with local nephrologists and hospitals in developing, owning, and operating these centers. The company was founded by Mark Caputo and Bob Santelli in 2002 and is headquartered in Mercer Island, WA.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada.

Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China.

Legacy Pharmaceuticals International LLC invests in pharmaceutical companies.

Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017.

Ignition Growth Management LLC (Ignition Capital) is a private equity subsidiary of Ignition Partners Group founded in 2007 by Jon Anderson, Rich Tong and John T. Zagula. The firm is headquartered in Bellevue, Washington.